Related Experiment Videos
Quantitative enzyme determination in acute myeloid leukemia.
G J Ossenkoppele1, P J Wijermans, P C Huijgens
1Department of Haematology, Free University Hospital, Amsterdam, The Netherlands.
Leukemia Research
|January 1, 1991
Summary
Quantitative enzyme analysis in acute myeloid leukemia (AML) cells revealed myeloperoxidase (MPO) and acid esterase levels can distinguish subtypes. Enzyme content also correlated with remission rates, suggesting prognostic value.
Area of Science:
- Hematology
- Oncology
- Biochemistry
Background:
- Acute myeloid leukemia (AML) is a heterogeneous disease.
- Accurate subclassification and prognostic markers are crucial for effective treatment.
Purpose of the Study:
- To investigate the utility of intracellular protein and enzyme content in freshly obtained leukemic cells for AML classification and prognosis.
- To correlate enzyme levels with FAB classification, cytochemical staining, and clinical features.
Main Methods:
- Analysis of intracellular protein and enzyme content (myeloperoxidase, acid esterase, lactate dehydrogenase) in 64 AML patient samples.
- Measurement of cell diameter.
- Comparison with French-American-British (FAB) classification, cytochemical staining, and clinical data.
- Logistic regression analysis to assess the impact on complete remission.
Main Results:
- Mean values of myeloperoxidase (MPO) and acid esterase differentiated pure myeloid leukemias, though with considerable overlap between subgroups.
- No correlation was found between cytochemical staining and quantitative enzyme determination.
- Logistic regression identified protein and alpha naphthyl butyrate (ANBE) content as significant predictors (p < 0.01) of complete remission.
Conclusions:
- Quantitative enzyme determination is a readily measurable parameter reflecting leukemic cell maturation.
- Enzyme content, particularly ANBE, may hold prognostic significance in AML, potentially aiding in treatment decisions.